FMR1 and fragile X syndrome: These structures were observed by using the recently developed R-loop antibody in PM cells and also FXS cells, in which the FMR1 gene transcription was reactivated by treatment with the DNA methylation inhibitor 5-aza-29-deoxycytidine (Groh et al., 2014; Loomis et al., 2014).